Generation and Characterization of a Nanobody Against SARS-CoV

The sudden emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) has caused global panic in 2003, and the risk of SARS-CoV outbreak still exists. However, no specific antiviral drug or vaccine is available; thus, the development of therapeutic antibodies against SARS-CoV is needed. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiang-Fan, He, Lei, Deng, Yong-Qiang, Qi, Shu-Hui, Chen, Yue-Hong, Zhang, Xiao-Lu, Hu, Shi-Xiong, Fan, Rui-Wen, Zhao, Guang-Yu, Qin, Cheng-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369142/
https://www.ncbi.nlm.nih.gov/pubmed/34403037
http://dx.doi.org/10.1007/s12250-021-00436-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369142/
https://www.ncbi.nlm.nih.gov/pubmed/34403037
http://dx.doi.org/10.1007/s12250-021-00436-1

Ejemplares similares